CAS 1013920-15-4

Vorolanib

CAS: 1013920-15-4

Vorolanib

Purezza: ≥95%

Peso molecolare: 439.48g/mol

Ref: 54-BUP04294

Vorolanib-d6

CAS: 1013920-15-4

Formula: C₂₃H₂₀D₆FN₅O₃

Peso molecolare: 445.53

Ref: 4Z-V-094002

Vorolanib

CAS: 1013920-15-4

Formula: C₂₃H₂₆FN₅O₃

Peso molecolare: 439.49

Ref: 4Z-V-094001

Vorolanib

CAS: 1013920-15-4

Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor.

Formula: C₂₃H₂₆FN₅O₃

Purezza: 97.35%

Colore e forma: Solid

Peso molecolare: 439.48

Ref: TM-T8491

Vorolanib-D6

Prodotto controllato

CAS: 1013920-15-4

Formula: C₂₃H₂₀D₆FN₅O₃

Colore e forma: Neat

Peso molecolare: 445.53

Ref: TR-V766027

Vorolanib

CAS: 1013920-15-4

Formula: C₂₃H₂₆N₅O₃F

Ref: TR-TRC-V766025

Vorolanib

Prodotto controllato

CAS: 1013920-15-4

Formula: C₂₃H₂₆N₅O₃F

Colore e forma: Neat

Peso molecolare: 439.48

Ref: TR-V766025

X-82 (Vorolanib)

CAS: 1013920-15-4

Vorolanib is a small molecule that binds to the death receptor 4 (DR4) and inhibits angiogenesis. Vorolanib is a member of the everolimus group. This drug has been shown to inhibit tumor growth in a mouse model of metastatic cancer by blocking the activation of DR4, which signals cells to grow, and by inhibiting the production of pro-angiogenic factors. Vorolanib has also been shown to have anti-inflammatory properties. Vorolanib binds to the death receptor 4 (DR4) and inhibits angiogenesis by blocking activation of this protein, which signals cells to grow, and by inhibiting the production of pro-angiogenic factors. Vorolanib also has anti-inflammatory properties due to its ability to suppress myeloid derived suppressor cells (MDSCs).

Formula: C₂₃H₂₆FN₅O₃

Purezza: Min. 95%

Peso molecolare: 439.4 g/mol

Ref: 3D-NQB92015